Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 46

1.

Ampullary cancer of intestinal origin and duodenal cancer - A logical clinical and therapeutic subgroup in periampullary cancer.

Chandrasegaram MD, Gill AJ, Samra J, Price T, Chen J, Fawcett J, Merrett ND.

World J Gastrointest Oncol. 2017 Oct 15;9(10):407-415. doi: 10.4251/wjgo.v9.i10.407. Review.

2.

Genomic alterations in mucins across cancers.

King RJ, Yu F, Singh PK.

Oncotarget. 2017 May 17;8(40):67152-67168. doi: 10.18632/oncotarget.17934. eCollection 2017 Sep 15.

3.

Immunohistochemical Study of MUC1 and MUC5AC Expression in Gall Bladder Lesions.

Bhoge A, Khandeparkar SGS, Joshi AR, Gogate B, Kulkarni MM, Bhayekar P.

J Clin Diagn Res. 2017 Jul;11(7):EC12-EC16. doi: 10.7860/JCDR/2017/26537.10230. Epub 2017 Jul 1.

4.

Pre-operative evaluation of circulating KL-6 levels as a biomarker for epithelial ovarian carcinoma and its correlation with tumor MUC1 expression.

Sato S, Kato T, Abe K, Hanaoka T, Yano Y, Kurosaki A, Yasuda M, Sekino T, Fujiwara K, Hasegawa K.

Oncol Lett. 2017 Jul;14(1):776-786. doi: 10.3892/ol.2017.6254. Epub 2017 May 25. Erratum in: Oncol Lett. 2017 Oct;14 (4):5051.

5.

Immunohistochemical Study of MUC1, MUC2 and MUC5AC Expression in Primary Breast Carcinoma.

Patel DS, Khandeparkar SGS, Joshi AR, Kulkarni MM, Dhande B, Lengare P, Phegade LA, Narkhede K.

J Clin Diagn Res. 2017 Apr;11(4):EC30-EC34. doi: 10.7860/JCDR/2017/26533.9707. Epub 2017 Apr 1.

6.

Dysregulation of signaling pathways associated with innate antibacterial immunity in patients with pancreatic cancer.

Słotwiński R, Słotwińska SM.

Cent Eur J Immunol. 2016;41(4):404-418. doi: 10.5114/ceji.2016.65140. Epub 2017 Jan 24. Review.

7.

Gastric Proteins MUC5AC and TFF1 as Potential Diagnostic Markers of Colonic Sessile Serrated Adenomas/Polyps.

Khaidakov M, Lai KK, Roudachevski D, Sargsyan J, Goyne HE, Pai RK, Lamps LW, Hagedorn CH.

Am J Clin Pathol. 2016 Nov 1;146(5):530-537. doi: 10.1093/ajcp/aqw142.

8.

Autophagy, autophagy-associated adaptive immune responses and its role in hematologic malignancies.

You L, Jin S, Zhu L, Qian W.

Oncotarget. 2017 Feb 14;8(7):12374-12388. doi: 10.18632/oncotarget.13583. Review.

9.

High Specificity in Circulating Tumor Cell Identification Is Required for Accurate Evaluation of Programmed Death-Ligand 1.

Schehr JL, Schultz ZD, Warrick JW, Guckenberger DJ, Pezzi HM, Sperger JM, Heninger E, Saeed A, Leal T, Mattox K, Traynor AM, Campbell TC, Berry SM, Beebe DJ, Lang JM.

PLoS One. 2016 Jul 26;11(7):e0159397. doi: 10.1371/journal.pone.0159397. eCollection 2016.

10.

A phase 1 dose-escalation study of NEO-102 in patients with refractory colon and pancreatic cancer.

Beg MS, Azad NS, Patel SP, Torrealba J, Mavroukakis S, Beatson MA, Wang XP, Arlen PM, Morse MA.

Cancer Chemother Pharmacol. 2016 Sep;78(3):577-84. doi: 10.1007/s00280-016-3108-5. Epub 2016 Jul 23.

11.

Progression-free and overall survival in ovarian cancer patients treated with CVac, a mucin 1 dendritic cell therapy in a randomized phase 2 trial.

Gray HJ, Benigno B, Berek J, Chang J, Mason J, Mileshkin L, Mitchell P, Moradi M, Recio FO, Michener CM, Secord AA, Tchabo NE, Chan JK, Young J, Kohrt H, Gargosky SE, Goh JC.

J Immunother Cancer. 2016 Jun 21;4:34. doi: 10.1186/s40425-016-0137-x. eCollection 2016.

12.

The diagnostic performance of serum MUC5AC for cholangiocarcinoma: A systematic review and meta-analysis.

Xuan J, Li J, Zhou Z, Zhou R, Xu H, Wen W.

Medicine (Baltimore). 2016 Jun;95(24):e3513. doi: 10.1097/MD.0000000000003513. Review.

13.

MUC1, MUC2, MUC5AC, and MUC6 in colorectal cancer: expression profiles and clinical significance.

Betge J, Schneider NI, Harbaum L, Pollheimer MJ, Lindtner RA, Kornprat P, Ebert MP, Langner C.

Virchows Arch. 2016 Sep;469(3):255-65. doi: 10.1007/s00428-016-1970-5.

14.

Significant obesity-associated gene expression changes occur in the stomach but not intestines in obese mice.

Chen J, Chen L, Sanseau P, Freudenberg JM, Rajpal DK.

Physiol Rep. 2016 May;4(10). pii: e12793. doi: 10.14814/phy2.12793.

15.

Clinicopathological observation of primary lung enteric adenocarcinoma and its response to chemotherapy: A case report and review of the literature.

Lin LI, Xu CW, Zhang BO, Liu RR, Ge FJ, Zhao CH, Jia RU, Qin QH, Stojsic J, Wang Y, Xu JM.

Exp Ther Med. 2016 Jan;11(1):201-207. Epub 2015 Nov 12.

16.

A novel association of neuropilin-1 and MUC1 in pancreatic ductal adenocarcinoma: role in induction of VEGF signaling and angiogenesis.

Zhou R, Curry JM, Roy LD, Grover P, Haider J, Moore LJ, Wu ST, Kamesh A, Yazdanifar M, Ahrens WA, Leung T, Mukherjee P.

Oncogene. 2016 Oct 27;35(43):5608-5618. doi: 10.1038/onc.2015.516. Epub 2016 Jan 25.

17.

Detection of EpCAM-positive microparticles in pleural fluid: A new approach to mini-invasively identify patients with malignant pleural effusions.

Roca E, Lacroix R, Judicone C, Laroumagne S, Robert S, Cointe S, Muller A, Kaspi E, Roll P, Brisson AR, Tantucci C, Astoul P, Dignat-George F.

Oncotarget. 2016 Jan 19;7(3):3357-66. doi: 10.18632/oncotarget.6581.

18.

Prognostic Significance of Mucin Antigen MUC1 in Various Human Epithelial Cancers: A Meta-Analysis.

Xu F, Liu F, Zhao H, An G, Feng G.

Medicine (Baltimore). 2015 Dec;94(50):e2286. doi: 10.1097/MD.0000000000002286. Review.

19.

MUC1 Predicts Colorectal Cancer Metastasis: A Systematic Review and Meta-Analysis of Case Controlled Studies.

Zeng Y, Zhang Q, Zhang Y, Lu M, Liu Y, Zheng T, Feng S, Hao M, Shi H.

PLoS One. 2015 Sep 14;10(9):e0138049. doi: 10.1371/journal.pone.0138049. eCollection 2015. Review.

20.

The O-Linked Glycome and Blood Group Antigens ABO on Mucin-Type Glycoproteins in Mucinous and Serous Epithelial Ovarian Tumors.

Vitiazeva V, Kattla JJ, Flowers SA, Lindén SK, Premaratne P, Weijdegård B, Sundfeldt K, Karlsson NG.

PLoS One. 2015 Jun 15;10(6):e0130197. doi: 10.1371/journal.pone.0130197. eCollection 2015.

Supplemental Content

Support Center